ResearcherSun Yat-sen UniversityNo recent work listed
Zhi Li
Matched on ORCID iD 0000-0002-7166-9874; OpenAlex author ID A5100629556. Sources: OpenAlex.
Their work
- Papers
- 7 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 23
2013: 1 paper · 2014: 3 papers · 2015: none · 2016: none · 2017: 1 paper · 2018: none · 2019: none · 2020: 1 paper · 2021: 1 paper
Papers 7
- Type 2 diabetes prevention diet and the risk of pancreatic cancer: A large prospective multicenter study. Co-author DOI 10.1016/j.clnu.2021.09.037↗
- GOLPH3 Promotes Cancer Growth by Interacting With STIP1 and Regulating Telomerase Activity in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.3389/fonc.2020.575358↗
- Cbl-b predicts postoperative survival in patients with resectable pancreatic ductal adenocarcinoma. Co-author DOI 10.18632/oncotarget.18714↗
- The combination of a nuclear HMGB1-positive and HMGB2-negative expression is potentially associated with a shortened survival in patients with pancreatic ducta… Co-author DOI 10.1007/s13277-014-2328-8↗
- Serum calcium level used as a prognostic predictor in patients with resectable pancreatic ductal adenocarcinoma. Last author DOI 10.1016/j.clinre.2014.01.012↗
- Overexpression of GOLPH3 is associated with poor prognosis and clinical progression in pancreatic ductal adenocarcinoma. Co-author DOI 10.1186/1471-2407-14-571↗
- B7-H3 overexpression in pancreatic cancer promotes tumor progression. Co-author DOI 10.3892/ijmm.2012.1212↗
Closest collaborators
The 23 strongest of 23 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Kebing Wang · 2 shared papers, 2014–2020 · strength 0.15
- Paper GOLPH3 Promotes Cancer Growth by Interacting With STIP1 and Regulating Telomerase Activity in Pancreatic Ductal Adenoca… DOI 10.3389/fonc.2020.575358↗
- Paper Overexpression of GOLPH3 is associated with poor prognosis and clinical progression in pancreatic ductal adenocarcinoma. DOI 10.1186/1471-2407-14-571↗
- Guo‐Chao Zhong · 1 shared paper, 2021 · strength 0.14
- Jianping Gong · 1 shared paper, 2021 · strength 0.14
- Yan Jiun Huang · 1 shared paper, 2021 · strength 0.14
- Pengfei Yang · 1 shared paper, 2021 · strength 0.14
- Qian Dong · 2 shared papers, 2014–2017 · strength 0.11
- Xiujuan Qu · 2 shared papers, 2014–2017 · strength 0.11
- Meifang He · 1 shared paper, 2020 · strength 0.11
- Wen Li · 1 shared paper, 2020 · strength 0.11
- Xiaofang Che · 1 shared paper, 2017 · strength 0.06
- Ce Li · 1 shared paper, 2017 · strength 0.06
- Yao Zhang · 1 shared paper, 2014 · strength 0.04
- Wei Jing · 1 shared paper, 2014 · strength 0.04
- Luanjing Zhang · 1 shared paper, 2014 · strength 0.04
- Xia Jing-tang · 1 shared paper, 2014 · strength 0.04
- Dechun Li · 1 shared paper, 2013 · strength 0.03
- Xin Zhao · 1 shared paper, 2013 · strength 0.03
- Hua Zhao · 1 shared paper, 2013 · strength 0.03
- Zixiang Zhang · 1 shared paper, 2013 · strength 0.03
- Yasuyuki Sasaguri · 1 shared paper, 2014 · strength 0.03
- Tomoko Kimura · 1 shared paper, 2014 · strength 0.03
- Sohsuke Yamada · 1 shared paper, 2014 · strength 0.03
- Toru Takeda · 1 shared paper, 2014 · strength 0.03
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.